Cardiac Arrest Treatment Market - Global Industry Analysis

Cardiac Arrest Treatment Market: by Treatment (Drugs [Vasopressors, Anti-arrhythmic Drugs, Anticholinergic Drugs, Corticosteroids, Fibrinolytic Drugs, Beta Blockers, and Others], and Medical Devices [Defibrillators, Cardiac Resynchronization Therapy, and Others)], and by Distribution Channel (Hospitals, Pharmacies, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025

Published Date: 17-Oct-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4877 Status : Published

Description

The report covers forecast and analysis for the global cardiac arrest treatment market. The study provides historic data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Million). In-depth secondary research is used to ascertain overall market size, top industry players, top treatments, industry associations, etc. Macro-economic indicators such as healthcare industry outlook, healthcare spending, research funding, GDP along with company websites, company annual reports, white papers, financial reports and other sources have also been considered to arrive at the indicated market numbers.

Cardiac arrest is a situation wherein the heart stops beating suddenly. This occurs when the demand for oxygen towards heart does not meet the requirement and results in the mortality of heart muscles cells causing a heart attack. Besides, there are several other reasons causing cardiac arrest like cardiomyopathy, coronary artery disease, Brugada syndrome, and long QT syndrome. Among these, the coronary artery disease is the most common cause for sudden cardiac arrest especially among people above 35 years’ age group.  The Brugada syndrome and long QT syndrome causes abnormal heart rate which develops a cardiac arrest problem within the body. The cardiomyopathy situation causes heart muscle to develop to abnormal size and causes cardiac arrest problems.

The study provides a decisive view on the cardiac arrest treatment market by segmenting the market based on treatment, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on treatment the market is segmented into drugs and medical devices. The drugs market is further segmented into anticholinergic drugs, vasopressors, anti-arrhythmic drugs, fibrinolytic drugs, corticosteroids, beta blockers, and others, and the medical devices market is further segmented into defibrillators, cardiac resynchronization therapy, and others. The drugs segment accounted for major share of the market in 2018.

Based on distribution channel the market is segmented into hospitals, pharmacies, and others. Hospitals segment held major share of the market in 2018, due to a large number of surgical procedures being performed in hospitals. Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. North America held the leading position in the market for cardiac arrest treatment. More than 750,000 new heart attack and 340,000 recurrent cases occur every year in the U.S. alone.

The study also includes drivers and restraints for the cardiac arrest treatment along with the impact they have on the demand over the forecast period. Besides, the report includes the study of opportunities and trends available in the cardiac arrest treatment market on global level. Increasing number of cases for cardiac arrest owing to lifestyle changes like alcohol consumption, high cholesterol, improper rest and sleep, smoking, stress, obesity, and high blood pressure are likely to boost market growth. . Besides, patients suffering from coronary artery disease are also more vulnerable to cardiac arrest. Moreover, growing sector of the geriatric population and rising pace of obesity is raising market growth significantly.

The report also provides company market share analysis in order to give a broader view of the key players in the market. Industry insights and information is delivered in the required format. ZMR develops a list of industry players (manufacturers), distributors, retailers and industry experts. Some of the players included in cardiac arrest treatment market are GE Healthcare, Pfizer Inc., Abbott, Bayer AG, Amgen Inc., Novartis AG, and Boston Scientific Corporation.

The report segments the cardiac arrest treatment market as follows:

Global Cardiac Arrest Treatment Market: Treatment Segment Analysis

  • Drugs
    • Vasopressors
    • Anti-arrhythmic Drugs
    • Anticholinergic Drugs
    • Corticosteroids
    • Fibrinolytic Drugs
    • Beta Blockers
    • Others (Colloids, Crystalloids)
  • Medical Devices
    • Defibrillators
    • Cardiac Resynchronization Therapy (CRT)
    • Others

Global Cardiac Arrest Treatment Market: Distribution Channel Segment Analysis

  • Hospitals
  • Pharmacies
  • Others

Global Cardiac Arrest Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Cardiac Arrest Treatment Market, 2016-2025 (USD Million)
    • 2.2. Cardiac Arrest Treatment Market, 2016-2025 (USD Million)
    • 2.3. Cardiac Arrest Treatment Market: Snapshot
  • Chapter 3. Cardiac Arrest Treatment Market - Industry Analysis
    • 3.1. Cardiac Arrest Treatment Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Treatment
      • 3.6.2. Market attractiveness analysis By Distribution Channel
      • 3.6.3. Market attractiveness analysis by Region
  • Chapter 4. Cardiac Arrest Treatment Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Cardiac Arrest Treatment Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Treatment launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Cardiac Arrest Treatment Market -Treatment Analysis
    • 5.1. Global Cardiac Arrest Treatment Market overview: By Treatment type
      • 5.1.1. Global Cardiac Arrest Treatment Market share, By Treatment,2018 and 2025
    • 5.2. Drugs
      • 5.2.1. Global Cardiac Arrest Treatment Market by Drugs, 2016-2025 (USD Million)
    • 5.3. Vasopressors
      • 5.3.1. Global Cardiac Arrest Treatment Market by Vasopressors, 2016-2025 (USD Million)
    • 5.4. Anti-arrhythmic Drugs
      • 5.4.1. Global Cardiac Arrest Treatment Market by Anti-arrhythmic Drugs, 2016-2025 (USD Million)
    • 5.5. Anticholinergic Drugs
      • 5.5.1. Global Cardiac Arrest Treatment Market by Anticholinergic Drugs, 2016-2025 (USD Million)
      • 5.5.2. Global Cardiac Arrest Treatment Market by Anticholinergic Drugs, 2016-2025 (USD Million)
    • 5.6. Corticosteroids
      • 5.6.1. Global Cardiac Arrest Treatment Market by Corticosteroids, 2016-2025 (USD Million)
    • 5.7. Fibrinolytic Drugs
      • 5.7.1. Global Cardiac Arrest Treatment Market by Fibrinolytic Drugs, 2016-2025 (USD Million)
    • 5.8. Beta Blockers
      • 5.8.1. Global Cardiac Arrest Treatment Market by Beta Blockers, 2016-2025 (USD Million)
    • 5.9. Others (Colloids, Crystalloids)
      • 5.9.1. Global Cardiac Arrest Treatment Market by Others (Colloids, Crystalloids), 2016-2025 (USD Million)
    • 5.10. Medical Devices
      • 5.10.1. Global Cardiac Arrest Treatment Market by Medical Devices, 2016-2025 (USD Million)
    • 5.11. Defibrillators
      • 5.11.1. Global Cardiac Arrest Treatment Market by Defibrillators, 2016-2025 (USD Million)
    • 5.12. Cardiac Resynchronization Therapy (CRT)
      • 5.12.1. Global Cardiac Arrest Treatment Market by Cardiac Resynchronization Therapy (CRT), 2016-2025 (USD Million)
    • 5.13. Others
      • 5.13.1. Global Cardiac Arrest Treatment Market by others, 2016-2025 (USD Million)
  • Chapter 6. Global Cardiac Arrest Treatment Market -Distribution Channel Analysis
    • 6.1. Global Cardiac Arrest Treatment Market overview: By Distribution Channel
      • 6.1.1. Global Cardiac Arrest Treatment Market share, By Distribution Channel, 2018 and 2025
    • 6.2. Hospitals
      • 6.2.1. Global Cardiac Arrest Treatment Market By Hospitals, 2016-2025 (USD Million)
    • 6.3. Pharmacies
      • 6.3.1. Global Cardiac Arrest Treatment Market By Pharmacies, 2016-2025 (USD Million)
    • 6.4. Others
      • 6.4.1. Global Cardiac Arrest Treatment Market by Other Distribution Channels, 2016-2025 (USD Million)
  • Chapter 7. Global Cardiac Arrest Treatment Market - Regional Analysis
    • 7.1. Global Cardiac Arrest Treatment Market overview: by Region
      • 7.1.1. Global Cardiac Arrest Treatment Marketshare, by Region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Cardiac Arrest Treatment Market, 2016-2025 (USD Million)
      • 7.2.2. North America Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
      • 7.2.3. North America Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S.Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.2.4.2. The U.S.Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.2.5.2. Rest of North America Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Cardiac Arrest Treatment Market, 2016-2025 (USD Million)
      • 7.3.2. Europe Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
      • 7.3.3. Europe Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.3.4. UK
        • 7.3.4.1. U.K.Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.3.4.2. U.K.Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.3.5.2. France Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.3.6.2. Germany Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of EuropeCardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.3.7.2. Rest of EuropeCardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Cardiac Arrest Treatment Market, 2016-2025 (USD Million)
      • 7.4.2. Asia Pacific Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
      • 7.4.3. Asia Pacific Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.4.4.2. China Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.4.5.2. Japan Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.4.6.2. India Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Cardiac Arrest Treatment Market, 2016-2025 (USD Million)
      • 7.5.2. Latin America Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
      • 7.5.3. Latin America Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.5.4.2. Brazil Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 7.5.5. Rest of LatinAmerica
        • 7.5.5.1. Rest of LatinAmerica Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
        • 7.5.5.2. Rest of LatinAmerica Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Cardiac Arrest Treatment Market, 2016-2025 (USD Million)
      • 7.6.2. The Middle East and Africa Cardiac Arrest Treatment Market revenue, By Treatment,2016-2025 (USD Million)
      • 7.6.3. The Middle East and Africa Cardiac Arrest Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. GE Healthcare
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Treatment Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Pfizer Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Treatment Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Abbott
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Treatment Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Bayer AG
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Treatment Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Amgen Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Treatment Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Novartis AG
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Treatment Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Boston Scientific Corporation
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Treatment Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed